The clinical significance of antibody to vascular endothelial cells after renal transplantation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Transplantation

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1034/j.1399-0012.16.s8.10.xPMID 12464133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.

  1999cited by this paper
• The UNOS Scientific Renal Transplant Registry.

  1999cited by this paper
• A study of endothelial cell-lymphocyte responses in human renal transplantation.

  1999influential reference
• Anti‐endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes

  1998cited by this paper
• Endothelial cells from diverse tissues exhibit differences in growth and morphology.

  1998cited by this paper
• A Review of Humoral Rejection in ABO-Incompatible KidneyTransplantation, with Local (Intrarenal) DIC as the Underlying Condition

  1997cited by this paper
• Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases.

  1997cited by this paper
• Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.

  1997cited by this paper
• Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells.

  1997cited by this paper
• Association of pretransplantation antiheart antibodies with clinical course after heart transplantation.

  1995cited by this paper
• THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG‐TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2

  1994cited by this paper
• Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion.

  1993cited by this paper
• THE CLINICAL SIGNIFICANCE OF ALLOSPECIFIC ANTIBODIES AGAINST ENDOTHELIAL CELLS DETECTED WITH AN ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY ASSAY FOR VASCULAR REJECTION AND GRAFT LOSS AFTER RENAL TRANSPLANTATION

  1993cited by this paper
• Risk factors for chronic rejection in renal allograft recipients.

  1993cited by this paper
• Modulation of mesangial cell proliferation by endothelial cells in coculture.

  1991cited by this paper
• Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation.

  1989cited by this paper
• Donor-specific lysis of human kidney proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes.

  1989cited by this paper
• ASSOCIATION OF ANTIIDIOTYPIC ANTIBODY WITH SUCCESSFUL SECOND TRANSPLANT OF A KIDNEY SHARING HLA ANTIGENS WITH THE PREVIOUS HYPERACUTELY REJECTED FIRST KIDNEY

  1989cited by this paper
• Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies eluted from rejected human renal allografts.

  1988cited by this paper
• Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch.

  1988cited by this paper
• Heterogeneity in endothelial cells from large vessels and microvessels.

  1987cited by this paper
• The association of antivascular endothelial cell antibody with hyperacute rejection: a case report.

  1986cited by this paper
• Vascular endothelial alloantigens in renal transplantation.

  1985cited by this paper
• THE VASCULAR ENDOTHELIAL CELL ANTIGEN SYSTEM

  1985cited by this paper
• The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney grafts.

  1983influential reference
• DEVELOPMENT OF DONOR‐SPECIFIC B LYMPHOCYTE ANTIBODIES AFTER RENAL TRANSPLANTATION: No CORRELATION WITH GRAFT OUTCOME1

  1979cited by this paper

• Causes for and Difficulties in Renal Transplantation

  2018cites this paper
• Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection

  2016cites this paper
• Isolated De Novo Antiendothelial Cell Antibodies and Kidney Transplant Rejection.

  2016cites this paper
• Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.

  2015cites this paper
• The fate of renal allografts hinges on responses of the microvascular endothelium.

  2013cites this paper
• De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection.

  2011cites this paper
• Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection

  2009cites this paper
• Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.

  2009cites this paper
• The alloantigen-independent factors brain death and cold ischemia : prospects for a better graft survival through different donor management concepts

  2009cites this paper
• Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection.

  2008cites this paper
• Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection.

  2008cites this paper
• AVALIAÇÃO DA PRESENÇA DE ANTICORPOS ANTI- HLA NO PRIMEIRO ANO DO TRANSPLANTE RENAL

  2007cites this paper
• Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases.

  2005cites this paper
• A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells

  2004cites this paper
• The role of B cells and alloantibody in the host response to human organ allografts

  2003cites this paper
• Kidney, testis and penile cancer

  2003cites this paper
• Dialysis and Transplantation

  2001cites this paper